Announcements Trials

Browse Landscape Eligibility

Clinical Trials

1 trials

Recent Start date Enrollment

Withdrawn × Abituzumab × Gastrointestinal × Clear all

Phase

Status

Completed 2 Withdrawn 1

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Colorectal Neoplasms 1

Interventions

Fluorouracil 50 Oxaliplatin 48 Gemcitabine 45 Leucovorin 40 Capecitabine 34 Bevacizumab 29 Irinotecan 24 Cisplatin 21 Radiosurgery 18 Radiotherapy 17 pembrolizumab 16 Nivolumab 16 Cetuximab 15 Sorafenib 14 Taxes 13 Paclitaxel 13 Biopsy 13 Surgical Procedures, Operative 12 atezolizumab 10 Drug Therapy 10 lenvatinib 9 durvalumab 9 Radiation 9 Magnetic Resonance Spectroscopy 9 Folfox protocol 9 Cyclophosphamide 9 Albumin-Bound Paclitaxel 9 spartalizumab 8 130-nm albumin-bound paclitaxel 8 regorafenib 7

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

NCT03688230 2020-03-18

AMELION

SFJ Pharmaceuticals, Inc.

Phase 2 Withdrawn

Gastrointestinal

Colorectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡